A new therapeutic protocol for the treatment of keloid scars: a retrospective study.


Journal

Journal of wound care
ISSN: 0969-0700
Titre abrégé: J Wound Care
Pays: England
ID NLM: 9417080

Informations de publication

Date de publication:
02 Mar 2021
Historique:
entrez: 17 3 2021
pubmed: 18 3 2021
medline: 30 6 2021
Statut: ppublish

Résumé

There are few means to treat large keloid scars, as exeresis-even if partial-impedes direct closure without tension in the absence of a flap or a skin graft. This study evaluates the efficacy, indications for use and limitations of a new therapeutic protocol, combining an extralesional keloid excision left to heal by secondary intention with a paraffin dressing and glucocorticoid ointment, followed by monthly intrascar injections of corticosteroids upon full re-epithelialisation. A retrospective study of patients treated for keloid scars by using the new therapeutic protocol. Scars were categorised as either healed or recurring. Their recurrence was scored according to the changes in functional signs and the scar volume. A total of 36 scars were studied. The mean follow-up was 14.1 months. Healing occurred in a mean of 6.8 weeks. The mean surface area was 21.6cm The healing rate in this study was close to that reported in the literature. Excision-healing by secondary intention could therefore be offered to patients for whom adherence is uncertain. The protocol in this study offers a straightforward, fast, accessible solution that does not appear to entail any risk of additional keloids. It could potentially offer a treatment option in case of failure of other treatments, large keloid scars or scalp keloids.

Identifiants

pubmed: 33729847
doi: 10.12968/jowc.2021.30.3.184
doi:

Substances chimiques

Glucocorticoids 0

Types de publication

Evaluation Study Journal Article

Langues

eng

Pagination

184-190

Auteurs

David Boccara (D)

Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75010 Paris, France.

Kevin Serror (K)

Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75010 Paris, France.

Sarah Chatelain (S)

Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75010 Paris, France.

Marc Chaouat (M)

Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75010 Paris, France.

Maurice Mimoun (M)

Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75010 Paris, France.

Laura Azoulay (L)

Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75010 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH